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CBA/N  mice bear an X-linked genetic defect in the function of thymus- 
independent (B) lymphocytes (1).  Several lines  of evidence suggest that this 
defect  results  from the failure  of  development of  a subpopulation of  B lympho- 
cytes  which is  found in mature mice of  normal strains  (2).  The most prominent 
defects  of  CBA/N mice are their  failure  to  respond to several  thymus-independ- 
ent antigens including the 2,4,6-trinitrophenyl  (TNP) and 2,4-dinitrophenyl 
(DNP)  derivatives of Ficoll (3), type III pneumococcal  polysaccharide (4), 
polyinosinic-polycytidilic  acid  (5),  levan and dextran (J.  J. Mond, D. E. Mosier, 
and W. E. Paul,  unpublished observations).  CBA/N mice display  less  profound 
but clear  defects  in  certain  thymus-dependent antibody responses (6).  Recently, 
we have shown that  mice with the CBA/N-immune defect  can respond  to  certain 
T-independent antigens, namely TNP-lipopolysaccharide  (TNP-LPS  [7]),  the 
TNP derivative  ofBruceUa  abortus  (TNP-BA)  I  and  TNP conjugates  ofpolyacryl- 
amide beads.  2  These results  suggest that T-independent antigens can be sepa- 
rated into  two groups  based on  the matrix in  which the  TNP group is  presented. 
Because of these findings, it was particularly striking  to find  that male 
progeny of  a cross  between CBA/N female and either  BALB/c or DBA/2 male 
mice, which are  hemizygous for  the CBAJN defect,  failed  to  respond to  phospho- 
rylcholine (PC) derivatives of all carriers  tested including several carriers 
which, if  derivatized  with TNP, would stimulate an anti-TNP response on the 
part of  these defective mice. This is a provocative finding because the response to 
this  PC  antigen  is  dominated by  antibody  of one  major  idiotype  (TEPC-15 
idiotype), the expression of which has been demonstrated to occur substantially 
later in life than the expression of many antibodies to other antigens,  most 
notably to the TNP group (8). 
Materials and Methods 
(CBAJN  ×  DBA/2)F1  and  (CBA/N  ×  BALB/c)FI male and female mice were obtained from 
Division of  Research Services, National Institutes of Health. Since the defect of  the CBA/N mice is 
X-linked, all F1 males resulting from crosses of normal males with CBA/N females are defective 
i  j. j. Mond, I. Scher, M. Blaese, D. E. Mosier, and W. E. Paul. Manuscript submitted for 
publication. 
2  j. j. Mond, D. E. Mosier, and W. E. Paul. Manuscript in preparation. 
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and similar to the CBA/N mouse in their immunological characteristics  while female progeny 
of such crosses are phenotypically normal. 
Antigens.  Antigens used in these studies included PC-ovalbumin (PC-OVA), PC-mycobacte- 
rium H37 Ra (PC-myco), PC-B. abortus  (PC-BA) and rough strain pneumococcus (R36A) which 
bears PC as an immunodominant determinant. Antigens were prepared by the method of Chese- 
bro and Metzger (9). 
Enumeration of Plaque-Forming Cells (PFC) and Anti-PC Antibodies.  PFC specific for phos- 
phorylcholine were enumerated by using cII polysaccharide conjugated to sheep erythrocytes (10). 
cII contains PC as a predominant antigen. All PFC were inhibitable with concentrations of PC < 
10  -4 M. PC antibodies bearing the TEPC 15 idiotype (T15) were determined by hemagglutination 
inhibition (HI) as previously described (11). 
Cell Culture.  Spleen cells were cultured in modified Mishell-Dutton medium containing 10% 
endotoxin free fetal calf serum and 5  x  10  -s M 2-mercaptoethanol in fiat bottom microtiter trays 
(Falcon no.  3040  Falcon Plastics,  Div. of BioQuest,  Oxnard,  Calif.) at a  density of 10  e cells in 
0.2  ml medium per well. Plates were incubated for 3-4 days in a  humidified 5% COs,  95%  air 
atmosphere.  Cells were collected and IgM PFC were enumerated by a  modification of Jerue and 
Nordin hemolysis in gel assay (12). 
Results and Discussion 
Results in Table I show T15 titers in CBA/N x DBA/2N defective F, males and 
their normal female littermates after immunization with 100  leg of PC-OVA, 
PC-Myco, or PC°BA or with 106 R36A organisms in complete Freund's adjuvant. 
F, male mice failed to mount T15  + responses to PC on T-dependent (OVA) or on 
T-independent (BA, R36A) carriers although these mice can respond to TNP on 
OVA (13) and on BA.' F~ females developed significant T15 responses as early as 
2 wk after immunization with each of these antigens. 
As noted above, it has been shown that CBA/N mice and (CBA/N x DBAJ2)F, 
males and females can respond to certain T-independent antigens including 
TNP-BA. To directly compare the immunogenicity  of PC and of TNP conjugates 
we studied in vitro primary responses to PC and TNP derivatives ofB. abortus 
as well as to R36A. 
In vitro responses of (CBA/N x  BALB/c)F, male and female spleen cells to 
PC-BA, TNP-BA, and R36A are presented in Table II. F, female cells respond to 
a wide dose range of dilutions of TNP°BA and of PC-BA.  In fact, the antibody 
responses ofF, female cells to TNP-BA and PC-BA are very comparable at high 
dilutions of organisms, suggesting that in F, female mice the two antigens have 
a  substantial similarity in immunogenicity. F,  male cells are able to mount 
significant anti-TNP responses to TNpoB. abortus,  although over a more narrow 
range of antigen concentrations than was true of F, female cells. However, F, 
male cells failed entirely to respond to PC°BA,  at all antigen concentrations 
tested. Similarly, they did not mount an anti-PC response to R36A despite the 
fact that F, female cells made a significant in vitro response to R36A. 
F~ male and female mice were also immunized with PC-BA intravenously and 
PFC  to  PC-sheep erythrocytes (SRBC)  were determined 4  and 6  days later 
(Table III). F~ female mice developed large numbers of direct PFC's which were 
shown to be PC specific by the capacity of PC to inhibit plaque formation. Pre- 
liminary experiments had established that the peak response of normal mice to 
PC-BA occurred 4-6 days after immunization, and was comparable in magni- 
tude in BALB/c and (CBA/N  x  DBA/2N)F~ female mice. In sharp contrast to 
these results, F, male mice formed no measurable anti-PC responses after such 1140  MOND  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE I 
T15 Responses of CBA/N  × DBA/2 F 1 Males and Females to 
Phosphorylcholine Conjugates of T-Dependent and T- 
Independent Carriers* 
HI titer (logs)  -+ SE 
F~8  F~ 
No Ag (5)~  0  0.6 ±  0.6 
PC-myco  (13)  0  5.5 ±  0.8 
PC-BA (4)  0  6.3 ±  0.6 
PC-OVA (7)  0  6.9 ±  1.2 
R36A (4)  0  4.9 ±  0.4 
* (CBA/N x  DBA/2N)F~  male and female mice were immunized with 100 pg of antigen or 106 
R36A  organisms  emulsified  in  complete  Freund's  adjuvant.  PC-royce  was  emulsified  in 
incomplete Freund's adjuvant. 2-6 wk later eera were essayed for T15 idiotype by HI. 
* Number of animals per group. 
TAI3LE II 
In Vitro Response of (CBA/N  x BALB/c) F  1 Males and Females 
to PC-BA, TNP-BA and R36A* 
Antigen  Dilution 
PFC/culture 
F~6  F~9 
PC-BA  10-'  0  12 
10  -s  0  76 
10  -s  0  158 
10  -7  0  75 
TNP-BA  10  -~  101  285 
10  -3  90  227 
10  -5  13  166 
10  -7  9  74 
R36A  10  -4  0  40 
10  -5  0  35 
10  -~  0  0 
* 106(CBA/N  x  DBA/2N)F~  male and female spleen cells were cultured in fiat bottom Falcon 
microtiter Mishell,  Dutton  medium.  Antigens were PC-BA, TNP-BA, and  R36A.  PFC  to 
PC-SRBC or to TNP-SRBC were determined 4 days later. Results represent means of duplicate 
wells. 
TABLE III 
In  Vivo Response of (CBA/N  x  BALB/c) F I Males and Females to PC-BA * 
PC-PFC/spleen 
Antigen  Ft ~  F19 
Day 4  Day 6  Day 4  Day 6 
PC-BA  0  0  83,750  ±  21,250  23,167  ±  10,925 
* (CBA/N  x  BALB/c) F~  male and female mice (three per group) were injected with a  10  -~ dilution of PC-BA 
intravenously.  On day 4 and 6 after immunization spleens were enumerated  for PFC to  PC-SRBC.  Results 
represent the mean ±  SEM of three individual animals. 
immunization. We have recently reported that such immunization with TNP- 
BA induces TNP-specific PFC in both male and female F1 mice.  1 
The inability of these genetically defective mice to mount anti-PC responses 
in the face of relatively normal ability to develop anti-TNP (13) antibodies as 
well as  antibodies to  other specificities including azobenzenearsonate and 3- 
nitro,  4-hydroxy, 5-bromophenyl acetyl  (J.  J.  Mond,  O.  M/ikel~i,  and  W.  E. MOND  ET  AL.  BRIEF  DEFINITIVE  REPORT  1141 
Paul,  unpublished  observations)  when  immunized  with  these  determinants 
conjugated to comparable carriers might be explained by the absence of precur- 
sers of anti-PC antibody-forming cells. Indeed, absence of such precursors and of 
PC-binding cells has been reported to occur in neonatal mice (14). It is possible 
that  defective mice  whose B-cell maturation  is  arrested  or  abnormal  might 
never develop lymphocytes expressing  this  late-appearing  receptor.  Alterna- 
tively, mice with CBA/N X-linked-immune defect may lack an entire lineage of 
B  lymphocytes. This lineage may be responsible for all of the PC response in 
normal strains either  (a) because the expression of V-region genes controlling 
the T15 idiotype and other PC specificities may be limited to cells of this lineage 
or (b) because cells of the alternative lineage are tolerized in the neonatal period 
by contact with PC-bearing environmental antigens. In either case, the CBA/N 
would lack the line of B cells responsive to PC-antigens in normal mice and thus 
would fail to respond to PC on any carrier.  A  final possibility is that  CBA/N 
mice do have PC-binding B cells but that these cells are defective in that they 
have a high threshold for activation or that they retain the high susceptibility to 
tolerance  induction  normally  associated with  very immature  B  cells.  In  any 
case, it seems most unlikely that the X-linked defect leading to the failure of 
CBA/N mice to respond to PC can represent the absence of a structural gene for 
anti-PC  antibody since neither  H-chain  (15)  or L-chain  (16)  genes have been 
reported to be X-linked. 
Summary 
Mice with the CBA/N defect are unresponsive to the hapten phosphorylcho- 
line (PC) even when presented on a variety ofimmunogenic carriers. Since these 
mice have the variable region gene for PC, their inability to respond may reflect 
deletion or suppression of the line of B lymphocytes which is responsible for the 
anti-PC response. 
We are grateful to William Humphrey, Jr. for expert technical assistance. 
Received for publication i  July 1977. 
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